S&P 500 7,723.39 ▲ 46.62 (+0.61%) DOW 52,389.06 ▲ 27.48 (+0.05%) NASDAQ 26,480.43 ▲ 311.05 (+1.19%) US Markets Closed â€ĸ 10:30 PM ET

NXL

Nexalin Technology, Inc.

Price Chart
Latest Quote

$1.64

-0.07 (-4.09%)
Current Price
Previous Close $1.71
Open $1.67
Day High $1.72
Day Low $1.59
Volume 69,458
Fetched: 2026-10-28T02:30:18
Stock Information
Shares Outstanding 1.05M
Cash Equivalents $1.00M
Revenue $217K
Net Income $-8.99M
Sector Healthcare
Industry Medical Devices
Market Cap $1.72M
EPS (TTM) $-14.10
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$200K
Sales$217K
Income$-8.99M
Book/sh$2.07
Cash/sh$0.96
Employees8
Financial Ratios
Quick Ratio0.71
Current Ratio1.25
Returns & Margins
ROA-119.22%
ROE-240.25%
Gross Margin86.16%
Operating Margin-18479.69%
Ownership
Insider Ownership24.58%
Institutional Ownership3.45%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-0.22
P/S7.92
P/B0.79
Analyst Data
Recommendationnone
Target Price$15.00
Technical Indicators
SMA20$3.33
SMA50$5.11
SMA200$11.19
RSI0.37
ATR0.3631
Shares Float625K
Short Float1.62%
Short Ratio0.76
Volatility4.11
Rel Volume0.02
Performance History
Week-23.36%
Month-61.59%
Quarter-84.86%
6 Months-85.23%
YTD-90.62%
Year-96.20%
3 Years-81.96%
10 Years-97.57%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-10-27 $1.64 69,500
2026-10-26 $1.71 51,700
2026-10-23 $1.86 25,400
2026-10-22 $2.03 20,500
2026-10-21 $2.03 89,400
2026-10-20 $2.14 245,700
2026-10-19 $2.36 58,000
2026-10-16 $2.35 22,300
2026-10-15 $2.45 33,000
2026-10-14 $2.51 42,500
2026-10-13 $2.64 95,800
2026-10-12 $3.36 75,200
2026-10-09 $3.63 68,000
2026-10-08 $4.11 427,500
2026-10-07 $4.32 90,900
2026-10-06 $4.50 107,800
2026-10-05 $5.43 326,400
2026-10-02 $5.73 1,366,300
2026-10-01 $7.55 62,336,600
2026-09-30 $4.28 7,100
2026-09-29 $4.35 64,700
2026-09-28 $4.27 5,700
About Nexalin Technology, Inc.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

📰 Latest News
No news articles available at the moment. Check back later for updates on NXL.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $61,373 $36,593 $25,688 $363,212
Cost Of Revenue $61,373 $36,593 $25,688 $363,212
Total Revenue $301,647 $168,721 $110,748 $1,321,357
Operating Revenue $274,156 $162,827 $109,379 $1,294,945
Expenses
Total Expenses $8,692,528 $7,923,367 $5,807,044 $3,154,388
Other Income Expense $161,508 $139,420 $1,086,422 $194,597
Other Non Operating Income Expenses $34,568 $9,310 $239,542 $171,681
Net Non Operating Interest Income Expense $8,240 $3,193 $-38,835 $-59,382
Operating Expense $8,631,155 $7,886,774 $5,781,356 $2,791,176
General And Administrative Expense $7,547,633 $6,695,890 $3,859,545 $2,791,176
Total Other Finance Cost - $-3,193 $38,835 $59,382
Interest Expense - - - $59,382
Interest Expense Non Operating - - - $59,382
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-8,222,181 $-7,607,182 $-4,648,709 $-1,697,816
Net Interest Income $8,240 $3,193 $-38,835 $-59,382
Interest Income $8,240 - - -
Normalized Income $-8,349,121 $-7,737,292 $-5,495,589 $-1,720,732
Net Income From Continuing And Discontinued Operation $-8,222,181 $-7,607,182 $-4,648,709 $-1,697,816
Total Operating Income As Reported $-8,390,881 $-7,754,646 $-5,696,296 $-1,833,031
Net Income Common Stockholders $-8,222,181 $-7,607,182 $-4,648,709 $-1,697,816
Net Income $-8,222,181 $-7,607,182 $-4,648,709 $-1,697,816
Net Income Including Noncontrolling Interests $-8,222,181 $-7,607,182 $-4,648,709 $-1,697,816
Net Income Continuous Operations $-8,222,181 $-7,607,182 $-4,648,709 $-1,697,816
Earnings From Equity Interest Net Of Tax $-1,048 $4,851 $0 -
Pretax Income $-8,221,133 $-7,612,033 $-4,648,709 $-1,697,816
Interest Income Non Operating $8,240 - - -
Operating Income $-8,390,881 $-7,754,646 $-5,696,296 $-1,833,031
Gross Profit $240,274 $132,128 $85,060 $958,145
Special Income Charges - $0 $615,000 $22,916
Per Share
Diluted EPS $-0.50 $-0.83 $-0.63 $-0.30
Basic EPS $-0.50 $-0.83 $-0.63 $-0.30
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-8,496,284 $-7,869,649 $-6,538,922 $-1,855,412
Total Unusual Items $126,940 $130,110 $846,880 $22,916
Total Unusual Items Excluding Goodwill $126,940 $130,110 $846,880 $22,916
Reconciled Depreciation $21,537 $15,107 $4,254 $535
EBITDA (Bullshit earnings) $-8,369,344 $-7,739,539 $-5,692,042 $-1,832,496
EBIT $-8,390,881 $-7,754,646 $-5,696,296 $-1,833,031
Diluted Average Shares $16,392,465 $9,215,772 $7,357,029 $5,572,402
Basic Average Shares $16,392,465 $9,215,772 $7,357,029 $5,572,402
Diluted NI Availto Com Stockholders $-8,222,181 $-7,607,182 $-4,648,709 $-1,697,816
Tax Provision $0 $0 $0 -
Gain On Sale Of Security $126,940 $130,110 $231,880 -
Research And Development $1,083,522 $1,190,884 $1,921,811 -
Selling General And Administration $7,547,633 $6,695,890 $3,859,545 $2,791,176
Other Gand A $5,668,350 $5,195,801 $2,471,629 $2,097,068
Salaries And Wages $1,879,283 $1,500,089 $1,387,916 $694,108
Other Special Charges - - $-615,000 $-22,916
Impairment Of Capital Assets - - - -
Fetched: 2026-10-24
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $3,411,937 $3,415,311 $3,101,107 $5,478,687
Total Assets $4,635,319 $4,222,732 $3,631,916 $7,432,136
Total Non Current Assets $336,049 $261,591 $202,024 $6,674
Goodwill And Other Intangible Assets $336,049 $260,727 $105,528 $0
Other Intangible Assets $336,049 $260,727 $105,528 -
Current Assets $4,299,270 $3,961,141 $3,429,892 $7,425,462
Other Current Assets $363,014 $293,597 $315,670 $272,282
Inventory $131,473 $174,578 $156,420 $154,370
Receivables $81,571 $13,043 $9,369 $4,875
Accounts Receivable $81,571 $13,043 $9,369 $4,875
Cash Cash Equivalents And Short Term Investments $3,723,212 $3,479,923 $2,948,433 $6,993,935
Cash And Cash Equivalents $654,783 $574,485 $580,230 $162,743
Other Non Current Assets - $864 - -
Investmentin Financial Assets - - $96,000 $0
Prepaid Assets - - - -
Cash Financial - - - -
Debt
Total Debt - $0 $4,463 $755,260
Long Term Debt And Capital Lease Obligation - - $0 $4,463
Current Debt And Capital Lease Obligation - - $4,463 $750,797
Net Debt - - - $537,257
Current Debt - - - $700,000
Other Current Borrowings - - - $200,000
Long Term Debt - - - -
Liabilities
Total Liabilities Net Minority Interest $887,333 $546,694 $425,281 $1,953,449
Total Non Current Liabilities Net Minority Interest $0 $0 $0 $4,463
Current Liabilities $887,333 $546,694 $425,281 $1,948,986
Payables And Accrued Expenses $399,333 $306,694 $270,818 $1,198,189
Payables $244,579 $155,949 $159,534 $658,367
Accounts Payable $244,579 $155,949 $159,534 $658,367
Current Notes Payable - - $0 $500,000
Interest Payable - - $0 $111,501
Current Deferred Liabilities - - - $0
Equity
Common Stock Equity $3,747,986 $3,676,038 $3,206,635 $5,478,687
Total Equity Gross Minority Interest $3,747,986 $3,676,038 $3,206,635 $5,478,687
Stockholders Equity $3,747,986 $3,676,038 $3,206,635 $5,478,687
Gains Losses Not Affecting Retained Earnings $406 $-513 $-405 $36,313
Other Equity Adjustments $406 $-513 $-405 $36,313
Retained Earnings $-92,867,412 $-84,645,231 $-77,038,049 $-72,389,340
Long Term Equity Investment - $864 $96,000 $0
Other
Ordinary Shares Number $19,186,346 $13,303,523 $7,436,562 $7,286,562
Share Issued $19,186,346 $13,303,523 $7,436,562 $7,286,562
Tangible Book Value $3,411,937 $3,415,311 $3,101,107 $5,478,687
Invested Capital $3,747,986 $3,676,038 $3,206,635 $6,178,687
Working Capital $3,411,937 $3,414,447 $3,004,611 $5,476,476
Total Capitalization $3,747,986 $3,676,038 $3,206,635 $5,478,687
Additional Paid In Capital $96,595,806 $88,308,478 $80,237,652 $77,824,427
Capital Stock $19,186 $13,304 $7,437 $7,287
Common Stock $19,186 $13,304 $7,437 $7,287
Pensionand Other Post Retirement Benefit Plans Current $488,000 $240,000 $150,000 $0
Current Accrued Expenses $154,754 $150,745 $111,284 $539,822
Other Short Term Investments $3,068,429 $2,905,438 $2,368,203 $6,831,192
Capital Lease Obligations - $0 $4,463 $55,260
Current Capital Lease Obligation - $0 $4,463 $50,797
Investments And Advances - $864 $96,000 $0
Net PPE - $0 $496 $6,674
Gross PPE - $0 $496 $8,855
Long Term Capital Lease Obligation - - $0 $4,463
Available For Sale Securities - - $96,000 -
Accumulated Depreciation - - $-2,684 $-2,181
Other Properties - - $496 $8,855
Current Deferred Revenue - - - $0
Machinery Furniture Equipment - - - -
Fetched: 2026-10-24
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-5,054,517 $-4,114,696 $-3,944,663 $-2,215,699
Operating Activities
Operating Cash Flow $-4,957,658 $-3,944,390 $-3,835,384 $-2,215,699
Cash Flow From Continuing Operating Activities $-4,957,658 $-3,944,390 $-3,835,385 $-2,215,699
Operating Gains Losses $-126,076 $-34,974 $-846,880 $-22,916
Investing Activities
Capital Expenditure $-96,859 $-170,306 $-109,279 -
Investing Cash Flow $-131,991 $-577,539 $4,452,872 $-6,794,879
Cash Flow From Continuing Investing Activities $-131,991 $-577,539 $4,452,872 $-6,794,879
Financing Activities
Issuance Of Capital Stock $4,646,397 $4,516,184 $0 $8,545,270
Financing Cash Flow $5,169,947 $4,516,184 $-200,000 $8,511,543
Cash Flow From Continuing Financing Activities $5,169,947 $4,516,184 $-200,000 $8,511,543
Net Common Stock Issuance $4,646,397 $4,516,184 $0 $8,545,270
Common Stock Issuance $4,646,397 $4,516,184 $0 $8,545,270
Other
End Cash Position $654,783 $574,485 $580,230 $162,743
Beginning Cash Position $574,485 $580,230 $162,743 $661,778
Changes In Cash $80,298 $-5,745 $417,487 $-499,035
Proceeds From Stock Option Exercised $523,550 $0 $0 $3,473
Net Investment Purchase And Sale $-35,132 $-407,233 $4,658,151 $-6,794,879
Sale Of Investment $40,725,000 $33,224,000 $41,278,241 $0
Purchase Of Investment $-40,760,132 $-33,631,233 $-36,620,090 $-6,794,879
Net Intangibles Purchase And Sale $-96,859 $-170,306 $-109,279 $0
Purchase Of Intangibles $-96,859 $-170,306 $-109,279 $0
Change In Working Capital $229,419 $121,654 $-768,862 $-634,066
Change In Other Current Liabilities $0 $-4,463 $-50,797 $-46,033
Change In Payables And Accrued Expense $340,638 $125,876 $-662,371 $-86,320
Change In Accrued Expense $252,009 $129,461 $-163,538 $99,107
Change In Payable $88,629 $-3,585 $-498,833 $-185,427
Change In Account Payable $88,629 $-3,585 $-498,833 $-185,427
Change In Prepaid Assets $-69,417 $22,073 $-43,388 $-229,114
Change In Inventory $26,725 $-18,158 $-7,812 $-142,852
Change In Receivables $-68,527 $-3,674 $-4,494 $253
Changes In Account Receivables $-68,527 $-3,674 $-4,494 $253
Stock Based Compensation $3,123,263 $3,560,509 $2,413,375 $270,670
Asset Impairment Charge $16,380 $0 $5,762 $31,067
Depreciation Amortization Depletion $21,537 $15,107 $4,254 $535
Depreciation And Amortization $21,537 $15,107 $4,254 $535
Amortization Cash Flow $21,537 $15,107 $3,751 $0
Amortization Of Intangibles $21,537 $15,107 $3,751 $0
Earnings Losses From Equity Investments $864 $95,136 $0 -
Gain Loss On Investment Securities $-126,940 $-130,110 $-231,880 -
Net Income From Continuing Operations $-8,222,181 $-7,607,182 $-4,648,709 $-1,697,816
Repayment Of Debt - $0 $-200,000 $-37,200
Net Issuance Payments Of Debt - $0 $-200,000 $-37,200
Net Short Term Debt Issuance - $0 $-200,000 $-37,200
Short Term Debt Payments - $0 $-200,000 $-37,200
Net Business Purchase And Sale - $0 $-96,000 $0
Purchase Of Business - $0 $-96,000 $0
Other Non Cash Items - $496 $5,676 $-163,173
Depreciation - $0 $503 $535
Issuance Of Debt - - - $0
Short Term Debt Issuance - - - $0
Change In Other Working Capital - - - $-130,000
Interest Paid Supplemental Data - - - -
Net Long Term Debt Issuance - - - -
Long Term Debt Payments - - - -
Long Term Debt Issuance - - - -
Net PPE Purchase And Sale - - - -
Purchase Of PPE - - - -
Fetched: 2026-10-24